罗哌卡因复合舒芬太尼行蛛网膜下腔麻醉在剖宫产术中的临床价值探讨  

The Clinical Value of Ropivacaine Combined with Sufentanil for Subarach⁃noid Anesthesia in Cesarean Section

作　　者：宋士斌 杨博 陆军[1] 毛雪华 SONG Shibin;YANG Bo;LU Jun;MAO Xuehua(Department of Anesthesiology,Shanghai Songjiang Sijing Hospital,Shanghai 201601,China)

机构地区：[1]上海市松江区泗泾医院麻醉科,上海201601

出　　处：《系统医学》2025年第1期165-168,共4页Systems Medicine

摘　　要：目的分析罗哌卡因复合舒芬太尼蛛网膜下腔麻醉对剖宫产的临床应用价值。方法非随机选取2022年5月—2024年5月上海市松江区泗泾医院收治的134例剖宫产产妇为研究对象。按麻醉方式不同分为两组,各67例。参照组使用罗哌卡因蛛网膜下腔麻醉,观察组在参照组基础上使用复合舒芬太尼蛛网膜下腔麻醉。比较两组产妇麻醉麻醉指标,Bromage评分、感觉阻滞最高平面、平均动脉压和不良反应发生情况。结果观察组麻醉起效时间短于参照组,麻醉持续时间与痛觉恢复时间长于参照组,差异有统计学意义(P均<0.05)。观察组产妇Bromage评分低于参照组,感觉阻滞最高平面优于参照组,差异有统计学意义(P均<0.05)。麻醉前,两组产妇动脉压对比,差异无统计学意义(P>0.05)。麻醉后,两组产妇动脉压均降低,但差异无统计学意义(P>0.05)。观察组麻醉不良反应发生率为13.43%(9/67),参照组为11.94%(8/67),两组对比,差异无统计学意义(χ^(2)=0.067,P>0.05)。结论剖宫产产妇采用罗哌卡因复合舒芬太尼蛛网膜下腔麻醉的持续时间更长,可稳定产妇动脉压,不增加麻醉不良反应。Objective To analyze the clinical application value of ropivacaine combined with sufentanil subarachnoid anesthesia in cesarean section.Methods From May 2022 to May 2024,134 parturients with cesarean section admitted to Shanghai Songjiang Sijing Hospital were non-randomly selected as the research objects.They were divided into two groups according to different anesthesia methods,with 67 cases in each group.The reference group was treated with ropivacaine subarachnoid anesthesia,and the observation group was treated with combined sufentanil subarachnoid an⁃esthesia on the basis of the reference group.The anesthesia indexes,Bromage score,the highest plane of sensory block,mean arterial pressure and adverse reactions were compared between the two groups.Results The onset time of anesthesia in the observation group was shorter than that in the reference group,and the duration of anesthesia and pain recovery time were longer than those in the reference group,the differences were statistically significant(all P<0.05).The Bromage score of the observation group was lower than that of the reference group,and the highest level of sensory block was better than that of the reference group,the differences were statistically significant(both P<0.05).Before anesthesia,there was no statistical significant difference in arterial pressure between the two groups(P>0.05).After anesthesia,the arterial pressure of the two groups decreased,but the difference was not statistically significant(P>0.05).The incidence of adverse reactions to anesthesia in the observation group was 13.43%(9/67),and that in the ref⁃erence group was 11.94%(8/67).There was no statistical significant difference between the two groups(χ^(2)=0.067,P>0.05).Conclusion The duration of subarachnoid anesthesia with ropivacaine combined with sufentanil in cesarean sec⁃tion is longer,which can stabilize the maternal arterial pressure and does not increase the adverse reactions of anesthe⁃sia.

关 键 词：罗哌卡因 舒芬太尼 蛛网膜下腔麻醉 剖宫产术 

分 类 号：R614[医药卫生—麻醉学]